(Q33501307)

27 July 2017

title

The impact of Filgrastim schedule variation on hematopoietic recovery post-chemotherapy (English)

1 reference

27 July 2017

1 reference

J Crawford

1

1 reference

27 July 2017

H Kreisman

2

1 reference

27 July 2017

H Garewal

3

1 reference

27 July 2017

S E Jones

4

1 reference

27 July 2017

D Shoemaker

5

1 reference

27 July 2017

M R Pupa

6

1 reference

27 July 2017

S Armstrong

7

1 reference

27 July 2017

D Tomita

8

1 reference

27 July 2017

G Dziem

9

1 reference

27 July 2017

publication date

1 November 1997

1 reference

27 July 2017

1 reference

27 July 2017

volume

8

1 reference

27 July 2017

issue

11

1 reference

27 July 2017

page(s)

1117-1124

1 reference

Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008271804151

7 January 2021

The use of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008271804151

7 January 2021

Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008271804151

7 January 2021

Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008271804151

7 January 2021

Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008271804151

7 January 2021

Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute Leukemia

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008271804151

7 January 2021

The impact of therapy with filgrastim (recombinant granulocyte colony-stimulating factor) on the health care costs associated with cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008271804151

7 January 2021

Decision analysis of hematopoietic growth factor use in patients receiving cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008271804151

7 January 2021

Identifiers

DOI

10.1023/A:1008271804151

1 reference

27 July 2017

1 reference